FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
SS Innovations International FCF Yield % Explanation
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
SS Innovations International FCF Yield % Related Terms
SS Innovations International FCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, SS Innovations International's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SS Innovations International FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, SS Innovations International's FCF Yield % distribution charts can be found below:
* The bar in red indicates where SS Innovations International's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SS Innovations International (SSII) has a FCF Yield % of -2.63 as of Jun. 26, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on SS Innovations International and its competitors. According to the industry distribution chart, SS Innovations International ranks #501 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 58.6%.
Is SS Innovations International's FCF Yield % too high?
SS Innovations International's current FCF Yield % is -2.63. Based on the distribution chart, SS Innovations International ranks #501 out of 855 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, SS Innovations International has a GF Score™ of 35/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does SS Innovations International's FCF Yield % compare to LMRI and AVR?
According to the Medical Devices & Instruments industry distribution chart, SS Innovations International ranks #501 out of 855 companies for FCF Yield %. This places SS Innovations International in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on SS Innovations International and its competitors. SS Innovations International's current FCF Yield % is -2.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SS Innovations International stock overvalued right now?
Based on GuruFocus' analysis, SS Innovations International (SSII) is currently considered Possible Value Trap. The stock's GF Value™ is $18.53, compared to a current price of $3.36 — trading 81.9% below its estimated fair value. The current FCF Yield % is -2.63. SS Innovations International's overall GF Score™ is 35/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For SS Innovations International (SSII), the current FCF Yield % is -2.63 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SS Innovations International (SSII) Overvalued in 2026?
Based on GuruFocus' analysis, SS Innovations International stock appears to be undervalued.
The current stock price of $3.36 is trading 81.9% below its estimated GF Value™ of $18.53.
GuruFocus considers SS Innovations International to be Possible Value Trap.
Key valuation signals for SSII:
FCF Yield %: -2.63
GF Value™: $18.53 vs. price of $3.36 (81.9% below fair value)
No single metric tells the full story. See the SSII stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SS Innovations International Inc is a commercial-stage surgical robotics company. It designs, manufactures, and markets a surgical robotic system called the SSi Mantra Surgical Robotic System (the SSi Mantra) intended for use in urology, general, gynecology, colorectal, gastroenterology, head and neck, thoracic, and cardiac surgeries. Additionally, the company offers a suite of stapling, energy, and core instrumentation for its surgical systems, under the brand name of SSi Mudra.
35GF Score
Get the complete analysis for SSII
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SSII has been successfully added to your 
